HEMACARE CORPORATION – Trademark Portfolio
Entity Type: 03
HEMACARE CORPORATION owns a portfolio of 29 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as GMPRIME, HEMACARE, and HEMAPRIME. Of these, 3 are registered. The portfolio spans 7 Nice Classification classes, led by Class 44 (Medical Services) and Class 35 (Advertising & Business). Headquartered in SHERMAN OAKS, CA.
4954 VAN NUYS BLVD.
SHERMAN OAKS, CA 91403
Showing of trademarks Trademarks
Trademark Classifications
HEMACARE CORPORATION's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does HEMACARE CORPORATION have?
HEMACARE CORPORATION has 29 U.S. trademarks filed with the USPTO. Of these, 3 registered, 10 abandoned, 16 cancelled.
What trademark classes does HEMACARE CORPORATION file in?
HEMACARE CORPORATION files trademarks across 7 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are HEMACARE CORPORATION's most well-known trademarks?
HEMACARE CORPORATION's registered trademark portfolio includes well-known marks such as GMPRIME, HEMACARE, and HEMAPRIME. These are among 3 currently registered trademarks in the portfolio.
What is HEMACARE CORPORATION's trademark registration success rate?
HEMACARE CORPORATION has a 10% trademark registration rate, with 3 out of 29 resolved applications resulting in successful registration. Currently, 0 applications are pending review.